Oxazepam Tablets CIV
Generic Name and Formulations:
Oxazepam 15mg; tabs; contains tartrazine.
Various generic manufacturers
Indications for Oxazepam Tablets:
Mild to moderate: 10–15mg 3–4 times daily. Severe: 15–30mg 3–4 times daily.
Renal, cardiovascular, or liver disease. Change dose gradually. Reevaluate periodically. Aspirin sensitivity (15mg tabs only). Monitor blood counts and liver function. Pregnancy, nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants.
CNS depression, drowsiness, dizziness, memory impairment, headache, ataxia, paradoxical excitement, hypotension, rash, nausea, edema, slurred speech, jaundice, blood dyscrasias, abuse potential.
Formerly known under the brand names Serax (caps, tabs); Zaxopam (caps).
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Guidelines for Management of Hypothalamic-Pituitary, Growth Disorders in Childhood Cancer Survivors
- Romosozumab: Effective in Men With Osteoporosis
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- NT-proBNP May Predict Cardiovascular Outcomes in Type 2 Diabetes
- Placebo Effect of Various Female Sexual Dysfunction Drug Txs Assessed
- Link Between Oral Diabetes Medications and Bullous Pemphigoid
- Calcium Channel Blocker May Benefit Patients With Type 1 Diabetes
- β-Cell Function in Youth With Impaired Glucose Tolerance, T2D